Cargando…
Unique characteristics of end-of-life hospitalizations in Parkinson disease
INTRODUCTION: Persons with Parkinson disease (PD) are hospitalized at higher rates, have longer lengths of stay, and are more likely to die in the hospital than age-matched peers. Although prior studies have compared inpatient outcomes between persons with and without PD, little is known about inpat...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10600520/ https://www.ncbi.nlm.nih.gov/pubmed/37901789 http://dx.doi.org/10.3389/fnagi.2023.1254969 |
_version_ | 1785126004280262656 |
---|---|
author | Aamodt, Whitley W. Dahodwala, Nabila Bilker, Warren B. Farrar, John T. Willis, Allison W. |
author_facet | Aamodt, Whitley W. Dahodwala, Nabila Bilker, Warren B. Farrar, John T. Willis, Allison W. |
author_sort | Aamodt, Whitley W. |
collection | PubMed |
description | INTRODUCTION: Persons with Parkinson disease (PD) are hospitalized at higher rates, have longer lengths of stay, and are more likely to die in the hospital than age-matched peers. Although prior studies have compared inpatient outcomes between persons with and without PD, little is known about inpatient outcomes across the PD trajectory, or whether hospitalizations occurring in the last 6 months of life differ from earlier hospitalizations. METHODS: This cross-sectional study compared Medicare Part A and B beneficiaries aged 65 and older with a qualifying PD diagnosis who were hospitalized in 2017: decedents who died between 7/1/2017 and 12/31/2017 from all causes and were hospitalized at least once in their last 6 months of life, and non-decedents who were hospitalized between 1/1/2017 and 6/30/2017 and lived 6 or more months after discharge. End-of-life (EoL) hospitalizations were defined as those occurring in the last 6 months of life. Descriptive analyses compared patient-level variables (e.g., demographics, comorbidities, treatment intensity) and encounter-level variables (e.g., length of stay, total charges) between groups. Multivariable logistic regression models also compared rates of intensive care unit (ICU) admission and 30-day readmission between hospitalized decedents and hospitalized non-decedents, adjusting for age, sex, race/ethnicity, rural residence, and Charlson Comorbidity Index Score. RESULTS: Of 26,492 Medicare decedents with PD, 16,187 (61.1%) were hospitalized in their last 6 months of life. Of 347,512 non-decedents with PD, 62,851 (18.1%) were hospitalized in a 6-month period. Hospitalized decedents were slightly older than hospitalized non-decedents (82.3 [SD 7.40] vs. 79.5 [SD 7.54] years) and had significantly more comorbidities. Compared to non-EoL hospitalizations, EoL hospitalizations were slightly longer (5 [IQR 3–9] vs. 4 [IQR 3–7] days) and more expensive based on total charges per admission ($36,323 [IQR 20,091-69,048] vs. $32,309 [IQR 18,789–57,756]). In covariate-adjusted regression models using hospitalized non-decedents as the reference group, hospitalized decedents were more likely to experience an ICU admission (AOR 2.36; CI 2.28–2.45) and 30-day readmission (AOR 2.43; CI 2.34–2.54). DISCUSSION: Hospitalizations occurring in the last 6 months of life among persons with PD in the United States are longer, more costly, and more resource intensive than earlier hospitalizations and may stem from medical comorbidities. Once hospitalized, ICU admission and 30-day readmission may aid in prognostication and serve as markers of transition to the EoL period. |
format | Online Article Text |
id | pubmed-10600520 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-106005202023-10-27 Unique characteristics of end-of-life hospitalizations in Parkinson disease Aamodt, Whitley W. Dahodwala, Nabila Bilker, Warren B. Farrar, John T. Willis, Allison W. Front Aging Neurosci Aging Neuroscience INTRODUCTION: Persons with Parkinson disease (PD) are hospitalized at higher rates, have longer lengths of stay, and are more likely to die in the hospital than age-matched peers. Although prior studies have compared inpatient outcomes between persons with and without PD, little is known about inpatient outcomes across the PD trajectory, or whether hospitalizations occurring in the last 6 months of life differ from earlier hospitalizations. METHODS: This cross-sectional study compared Medicare Part A and B beneficiaries aged 65 and older with a qualifying PD diagnosis who were hospitalized in 2017: decedents who died between 7/1/2017 and 12/31/2017 from all causes and were hospitalized at least once in their last 6 months of life, and non-decedents who were hospitalized between 1/1/2017 and 6/30/2017 and lived 6 or more months after discharge. End-of-life (EoL) hospitalizations were defined as those occurring in the last 6 months of life. Descriptive analyses compared patient-level variables (e.g., demographics, comorbidities, treatment intensity) and encounter-level variables (e.g., length of stay, total charges) between groups. Multivariable logistic regression models also compared rates of intensive care unit (ICU) admission and 30-day readmission between hospitalized decedents and hospitalized non-decedents, adjusting for age, sex, race/ethnicity, rural residence, and Charlson Comorbidity Index Score. RESULTS: Of 26,492 Medicare decedents with PD, 16,187 (61.1%) were hospitalized in their last 6 months of life. Of 347,512 non-decedents with PD, 62,851 (18.1%) were hospitalized in a 6-month period. Hospitalized decedents were slightly older than hospitalized non-decedents (82.3 [SD 7.40] vs. 79.5 [SD 7.54] years) and had significantly more comorbidities. Compared to non-EoL hospitalizations, EoL hospitalizations were slightly longer (5 [IQR 3–9] vs. 4 [IQR 3–7] days) and more expensive based on total charges per admission ($36,323 [IQR 20,091-69,048] vs. $32,309 [IQR 18,789–57,756]). In covariate-adjusted regression models using hospitalized non-decedents as the reference group, hospitalized decedents were more likely to experience an ICU admission (AOR 2.36; CI 2.28–2.45) and 30-day readmission (AOR 2.43; CI 2.34–2.54). DISCUSSION: Hospitalizations occurring in the last 6 months of life among persons with PD in the United States are longer, more costly, and more resource intensive than earlier hospitalizations and may stem from medical comorbidities. Once hospitalized, ICU admission and 30-day readmission may aid in prognostication and serve as markers of transition to the EoL period. Frontiers Media S.A. 2023-10-12 /pmc/articles/PMC10600520/ /pubmed/37901789 http://dx.doi.org/10.3389/fnagi.2023.1254969 Text en Copyright © 2023 Aamodt, Dahodwala, Bilker, Farrar and Willis. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Aging Neuroscience Aamodt, Whitley W. Dahodwala, Nabila Bilker, Warren B. Farrar, John T. Willis, Allison W. Unique characteristics of end-of-life hospitalizations in Parkinson disease |
title | Unique characteristics of end-of-life hospitalizations in Parkinson disease |
title_full | Unique characteristics of end-of-life hospitalizations in Parkinson disease |
title_fullStr | Unique characteristics of end-of-life hospitalizations in Parkinson disease |
title_full_unstemmed | Unique characteristics of end-of-life hospitalizations in Parkinson disease |
title_short | Unique characteristics of end-of-life hospitalizations in Parkinson disease |
title_sort | unique characteristics of end-of-life hospitalizations in parkinson disease |
topic | Aging Neuroscience |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10600520/ https://www.ncbi.nlm.nih.gov/pubmed/37901789 http://dx.doi.org/10.3389/fnagi.2023.1254969 |
work_keys_str_mv | AT aamodtwhitleyw uniquecharacteristicsofendoflifehospitalizationsinparkinsondisease AT dahodwalanabila uniquecharacteristicsofendoflifehospitalizationsinparkinsondisease AT bilkerwarrenb uniquecharacteristicsofendoflifehospitalizationsinparkinsondisease AT farrarjohnt uniquecharacteristicsofendoflifehospitalizationsinparkinsondisease AT willisallisonw uniquecharacteristicsofendoflifehospitalizationsinparkinsondisease |